In case you missed it: June 27 to July 1
A look back at the week's news.
Not just abortion: How the demise of Roe v Wade may impact fertility care
As we were going to press with the July issue, the United States Supreme Court overturned Roe v Wade, eliminating the constitutional right to an abortion, and leaving the question of abortion rights to the states.
Pharmacies limiting Plan B purchases after Roe v. Wade reversal
The American Medical Association is urging the FDA to approve OTC access to oral contraceptives.
HHS secretary details department’s efforts to protect reproductive health care
“The impact was visible and real,” said Xavier Becerra, secretary of the US Department for Health and Human Services during a press conference Tuesday.
SOGH responds to Roe v Wade decision
The Society of Ob/Gyn Hospitalists released a statement on the Supreme Court Decision overturning Roe v Wade.
Buprenorphine use in pregnancy linked to decreased fetal breathing movements
May 18th 2024According to a poster presented at ACOG 2024, use of the synthetic opioid buprenorphine depressed fetal breathing in biophysical profile assessments, but had no significant impact on other factors like amniotic fluid index or fetal tone.
Read More
